• Memorial Sloan-Kettering Cancer Center, New York, NY - Surgical Oncology
• Harvard Medical School - Cancer Biology
• Beth Israel Deaconess Medical Center, Boston, MA - General Surgery
• McGill University, Quebec, Canada - Medicine
Dr. David Shibata is a Surgical Oncologist and Chief of the Section of Colorectal Oncology in the Gastrointestinal Oncology Department at Moffitt Cancer Center where he has been since 2004. He is Professor of Surgery and Oncology at the University of South Florida College of Medicine. He is the Associate Program Director of the Surgical Oncology Fellowship and Site Program Director of the USF General Surgery Residency at Moffitt.
Dr. Shibata attended medical school at McGill University in Montreal, Canada and received his General Surgery training at the Beth Israel Deaconess Medical Center in Boston, MA. He completed a Research Fellowship in Cancer Biology at Harvard Medical School and a Surgical Oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York.
Dr. Shibata’s clinical practice is dedicated to the treatment of patients with colorectal cancer. He is particularly interested in laparoscopic/minimally invasive approaches to the treatment of colorectal cancer as well as sphincter-preserving techniques for patients with rectal cancer. He is the medical director of the High Risk/Hereditary Colorectal Cancer and the Colorectal Cancer Survivorship Clinics at Moffitt Cancer Center. Dr. Shibata sits on the panel of the National Comprehensive Cancer Network (NCCN) that establishes national guidelines for the treatment of patients with colorectal cancer.
He is actively involved in colorectal cancer clinical research and clinical trials. Dr. Shibata's laboratory research is funded by the National Cancer Institute and centers on the study of specific molecular mechanisms such as DNA methylation that contribute to the development of colorectal cancer.